[{"Assets_0_Q1_USD":396349000.0,"CommonStockSharesConverted_0_Q1_shares":35922248.0,"CommonStockSharesOutstanding_0_Q1_shares":35922248.0,"EarningsPerShareBasic_1_Q1_USD":-1.69,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":-27866000.0,"NetIncomeLossConverted_1_Q1_USD":-60718000.0,"StockholdersEquity_0_Q1_USD":381707000.0,"Ticker":"TPTX","CIK":"1595893","name":"TURNING POINT THERAPEUTICS, INC.","OfficialName":"Turning Point Therapeutics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1579986704.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200512"}]